))
This is my first episode about Rheumatoid Arthritis explaining some general information about the disease.
…
continue reading
Interview Cover art photo provided by Janine Joles on Unsplash: https://unsplash.com/@joyful_janine
…
continue reading
Rheumatoid arthritis is a chronic long term condition that principally attacks flexible joints, causing painful swelling, stiffness and fatigue. The risk of developing RA is associated with ageing but it also affects adults of working age and is three times more common in women. 56 year old Liz noticed her first symptoms in 1996, when her son was just 2 years old. In this collection, she shares her experiences of living with RA, from early symptoms to drug-controlled remission.
…
continue reading
Biologic Therapy in Rheumatoid Arthritis: Pioneers in Research, is a monthly series of podcasts featuring interviews with today's giants in rheumatology sponsored by Schering-Plough Corporation. In this series brought to you by Rheumatology News International, you will hear some of the greatest scientists in rheumatology describe the exploration of what was then uncharted medical territory. Their words will bring alive the journey of discovery that placed them in the annals of history's grea ...
…
continue reading
This is my first episode about Rheumatoid Arthritis describing general information about the disease
…
continue reading
Interveiw
…
continue reading
Liz, who was diagnosed with RA in 1996, talks about living with this long term condition.The Open University
…
continue reading
Liz talks about how she felt, physically and emortionally, when the condition first manifested itself.The Open University
…
continue reading
Liz looks back on about the protracted process of getting a diagnosis.The Open University
…
continue reading
Liz talks about the various medications she has had since her condition was first diagnosed and how she is now in drug-controlled remission.The Open University
…
continue reading
Liz reflects on how her life has changed as a result of her long term condition.The Open University
…
continue reading
This sixth podcast program, Individualizing Therapy: Today’s Options, Tomorrow’s Opportunities, features an interview with Professor McInnes. He discusses the current state of knowledge in rheumatoid arthritis and directions for discovery in coming years.rhnews@elsevier.com (Rheumatology News International)
…
continue reading
This fifth podcast titled Progress and Prognosis: Evaluating Patients’ Responses to Biologic Therapy features a telephone interview with Professor Schett. He discusses differences among the anti-TNF agents in the treatment of rheumatoid arthritis.rhnews@elsevier.com (Rheumatology News International)
…
continue reading
1
Episode 4: Individualizing Treatment in Rheumatoid Arthritis: The Crucial Impact of Patient Heterogeneity
14:21
Professor VonVollenhoven discusses factors which distinguish individual responses by patients with rheumatoid arthritis to various anti-TNF agents. He describes observations of radiologic and clinical progression of illness in subgroups of patients and provides an overview of considerations in choosing one pharmacologic agent over another. Professo…
…
continue reading
1
Episode 3: Anti-TNF Treatment: Focus on early Rheumatoid Arthritis. Featuring an interview with Professor Paul Emery
14:21
Contemporary research shows that the early diagnosis and treatment of RA can offer patients the possibility of achieving remission. The goal for any patient with early RA should be to achieve remission. If a patient does not already have joint damage, the goal should be a normal acute-phase response and no swollen joints as soon as possible.…
…
continue reading
Professor Smolen discusses the evidence supporting the ability of TNF-alpha agents to result in substantial and sustained improvement in symptoms of psoriatic arthritis. Agents including infliximab and etanercept result in not only clinical improvement but also slow the radiographic progression of joint disease and damage. Further, the combination …
…
continue reading
Professor Sir Ravinder Maini's groundbreaking work on the characterization of TNF-alpha began in the mid-1980's with his collaboration with Professor Mark Feldman. In his study of intercellular messenger molecules, Professor Sir Maini utilized two new technologies -- protein sequencing and cDNA protein coding -- to investigate half a dozen cytokine…
…
continue reading
